Diabetes in Primary Care course MCQ Answers 2016
|
|
- Kory Long
- 7 years ago
- Views:
Transcription
1 Diabetes in Primary Care course MCQ Answers 2016 Diagnosis of Diabetes HbA1C should not be used as a diagnostic tool in the following situations: (answer each TRUE or FALSE) 1. Gestational Diabetes TRUE 2. Chronic iron deficiency anaemia TRUE 3. Steroid-induced diabetes FALSE 4. Pancreatic diabetes TRUE 5. Recent blood transfusion TRUE Classification of Diabetes The following are typical features of Maturity Onset Diabetes of the Young (MODY): (answer each TRUE or FALSE) 1. Low or absent C-peptide levels FALSE 2. Overweight or obese BMI FALSE 3. Presence of pancreatic autoantibodies FALSE 4. Insulin dependence FALSE 5. Marked features of insulin resistance FALSE Pre-diabetes & the prevention of T2D The Finnish Diabetes Prevention Study demonstrated that early intensive lifestyle intervention can prevent the progression to T2DM. The NNT to prevent 1 case of T2DM over 13 years of follow-up was: (choose one) 1. 5 * HbA1C Targets in Diabetes The recently published NICE guidance on the management of T1DM encourage us to support all adults with T1DM to aim for a target HbA1C of: (choose one) 1. 42mmol/mol (6%) 2. 48mmol/mol (6.5%)* 3. 53mmol/mol (7%) 4. 58mmol/mol (7.5%) 5. 64mmol/mol (8%)
2 Tight glycaemic control ideally striving for an HbA1C 48mmol/mol (6.5%) is appropriate for the following patients: (answer each TRUE or FALSE) 1. A 70-year-old man with >10 years duration T2DM FALSE 2. A 40-year-old lady newly diagnosed with T2DM TRUE 3. A 65-year-old man with a background of IHD and stenting and T2DM for 7 years FALSE 4. A 55-year-old man with inoperable pancreatic cancer and pancreatic diabetes FALSE 5. A 70-year-old man with dementia and newly diagnosed T2DM FALSE Dietary management and behaviour change in diabetes The following are structured education programmes for T2DM: (answer each TRUE or FALSE) 1. DESMOND TRUE 2. X-PERT TRUE 3. BERTIE FALSE 4. DAFNE FALSE 5. RECLAIM FALSE Examples of low glycaemic index (GI) foods include: (answer each TRUE or FALSE) 1. Cornflakes FALSE 2. Baked potatoes FALSE 3. Muesli TRUE 4. Cow s milk TRUE 5. Cous cous FALSE When counting carbohydrates, 1 carbohydrate serving equals how many grams of carbohydrate: (choose one) 1. 5g 2. 10g 3. 15g* 4. 20g 5. 25g 1 pint of draught Guinness contains how many calories: (choose one) kcal kcal* kcal kcal kcal
3 The Pharmacological Management of Hyperglycaemia At what egfr should metformin therapy be stopped due to concerns regarding lactic acidosis: * No need to stop The following drugs do not cause hypoglycaemia (answer each TRUE or FALSE) 1. Metformin TRUE 2. Sulphonylureas FALSE 3. Pioglitazone TRUE 4. Gliptins TRUE 5. GLP1 analogues TRUE The following drugs do not cause weight gain (answer each TRUE or FALSE) 1. Metformin TRUE 2. Sulphonylureas FALSE 3. Pioglitazone FALSE 4. Gliptins TRUE 5. GLP1 analogues TRUE The following classes of drugs have established cardiovascular safety data (answer each TRUE or FALSE) 1. Metformin TRUE 2. Sulphonylureas FALSE 3. SGLT2 inhibitors TRUE 4. Gliptins TRUE 5. GLP1 analogues TRUE NICE recommends the following as first line treatment when starting insulin therapy in T2DM (answer each TRUE or FALSE) 1. Biphasic (pre-mixed) insulin e.g. Humulin M3 FALSE 2. Long-acting insulin analogue e.g. insulin glargine (Lantus) FALSE 3. Rapid-acting insulin e.g. Novorapid FALSE 4. Ultra-lomg acting insulin e.g. insulin degludec (Tresiba) FALSE 5. Human isophane insulin e.g. Insulatard TRUE
4 The following insulin types need to be resuspended prior to injection: (answer each TRUE or FALSE) 1. Biphasic (pre-mixed) insulin e.g. Humulin M3 TRUE 2. Long-acting insulin analogue e.g. insulin glargine (Lantus) FALSE 3. Rapid-acting insulin e.g. Novorapid FALSE 4. Ultra-lomg acting insulin e.g. insulin degludec (Tresiba) FALSE 5. Human isophane insulin e.g. Insulatard TRUE The following GLP1 drugs are administered weekly: (answer each TRUE or FALSE) 1. Exenatide (Bydureon) TRUE 2. Exenatide (Byetta) FALSE 3. Lixisenatide (Lyxumia) FALSE 4. Liraglutide (Victoza) FALSE 5. Dulaglutide (Trulicity) TRUE The following GLP1 drugs should be administered up to 1 hour before food: (answer each TRUE or FALSE) 1. Exenatide (Bydureon) FALSE 2. Exenatide (Byetta) TRUE 3. Lixisenatide (Lyxumia) TRUE 4. Liraglutide (Victoza) FALSE 5. Dulaglutide (Trulicity) FALSE Diabetes in Pregnancy Which of the following are the NICE 2015 criteria for diagnosing gestational diabetes: (choose one)? 1. FBG 5.1mmol/l or 2hr BG post 75g OGTT 8.5mmol/l 2. FBG 5.6mmol/l or 2hr BG post 75g OGTT 7.8mmol/l * 3. FBG 5.6mmol/l or 2hr BG post 75g OGTT 11.1mmol/l 4. FBG 7.0mmol/l or 2hr BG post 75g OGTT 7.8mmol/l 5. FBG 7.0mmol/l or 2hr BG post 75g OGTT 11.1mmol/l The management of cardiovascular risk factors in diabetes According to NICE CG181 July 2014: CV risk assessment and reduction, the following people should be offered atorvastatin 20mg: (answer each TRUE or FALSE) 1. A 34-year-old female who developed T1DM aged 21 years TRUE 2. All those aged over 40 years with T2DM FALSE 3. A 44-year-old man with T2DM and CKD3 TRUE 4. A 42-year-old female with T2DM and a 10-year CV risk score of 12% TRUE 5. An 18-year-old man newly diagnosed with T1DM FALSE
5 Diabetic nephropathy 1. A person with egfr 25 and ACR 15 is classified as having CKD G4A3 FALSE 2. Increased ACR and decreased GFR in combination multiple the risk of adverse outcomes TRUE 3. CKD is an independent risk factor for developing CVD TRUE 4. CKD does not directly cause hypoglycaemia FALSE 5. Lowering HbA1C to 53mmol/mol (7%) improves renal outcomes in CKD FALSE Diabetic foot disease The foot assessment of the following people with T2DM would be classified as moderate risk: (answer each TRUE or FALSE) 1. Peripheral pulses present and sensation intact but evidence of callus formation TRUE 2. Peripheral pulses present, sensation and skin intact but inappropriate footwear FALSE 3. History of previous foot ulceration since successfully treated FALSE 4. Peripheral pulses present but loss of monofilament sensation and skin intact TRUE 5. Unexplained hot, red, swollen foot FALSE Depression and distress in diabetes 1. Depression and anxiety is 5 times as common in those with T1DM and T2DM compared to the general population FALSE 2. Depression in diabetes is associated with an increased risk of mortality TRUE 3. Major depression in T2DM is associated with an increased risk of macrovascular and macrovascular complications TRUE 4. Paroxetine is the best option for treating depression in diabetes FALSE 5. Diabetes distress is a DSM-V defined disorder FALSE Diabetic neuropathy The following conditions can mimic painful diabetic neuropathy (answer each TRUE or FALSE) 1. Osteoarthritis TRUE 2. Intermittent claudication TRUE 3. Plantar fasciitis TRUE 4. Tarsal tunnel syndrome TRUE 5. Radiculopathy TRUE
6 Abnormal blood tests in diabetes 1. Around 50% of men with T2Dm have evidence of hypogonadotrophic hypogonadism FALSE 2. Testosterone levels of 8nmol/L are suggestive of a true androgen deficiency in an overweight person with T2DM FALSE 3. In those with established hypothyroidism levothyroxine dose should be increased by 25mcg as soon as pregnancy is confirmed TRUE 4. All those with T2DM need an annual check of TFTs FALSE 5. An AST:ALT ratio of 1.1 suggests NAFLD with a low risk of progression to NASH FALSE Diabetic emergencies 1. DKA is always associated with hyperglycaemia FALSE 2. The mortality rate associated with hyperosmolar hyperglycaemic state is around 1-2% FALSE 3. The rate of hypoglycaemia in those with T2DM managed with sulphonylureas is similar to those with T2DM on insulin TRUE 4. Renal impairment doubles the risk of hypoglycaemia in T2DM TRUE 5. A blood ketone level of 3mmol/l can be safely managed at home FALSE
SHORT CLINICAL GUIDELINE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SHORT CLINICAL GUIDELINE SCOPE 1 Guideline title Type 2 diabetes: newer agents for blood glucose control in type 2 diabetes 1.1 Short title Type 2
More informationDiabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions
Diabetes Mellitus 1 Chapter 43. Diabetes Mellitus, Self-Assessment Questions 1. A 46-year-old man presents for his annual physical. He states that he has been going to the bathroom more frequently than
More informationType 2 Diabetes workshop notes
Group 1 notes Abi / Nicole Type 2 Diabetes workshop notes 4.1 Population The group discussed the following sub groups that may need addressing: Men-as they tend to die earlier compared with women, their
More informationWorkshop A Tara Kadis
Workshop A Tara Kadis Considerations/barriers in decision making about insulin verses GLP-1 use in people with type 2 diabetes Which Insulin regimes should we consider? Diabetes is a progressive multi-system
More informationTYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS
TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS The aim of the Diabetes level 2 service is to provide a high quality service for safe initiation and optimization of injectable therapy within GP networks.
More informationTherapy Insulin Practical guide to Health Care Providers Quick Reference F Diabetes Mellitus in Type 2
Ministry of Health, Malaysia 2010 First published March 2011 Perkhidmatan Diabetes dan Endokrinologi Kementerian Kesihatan Malaysia Practical guide to Insulin Therapy in Type 2 Diabetes Mellitus Quick
More informationInsulin or GLP1 How to make this choice in Practice. Tara Kadis Lead Nurse - Diabetes & Endocrinology Mid Yorkshire Hospitals NHS Trust
Insulin or GLP1 How to make this choice in Practice Tara Kadis Lead Nurse - Diabetes & Endocrinology Mid Yorkshire Hospitals NHS Trust Workshop Over View Considerations/barriers to treatments in type 2
More informationInsulin use in Type 2 Diabetes. Dr Rick Cutfield. Why? When? How?
Insulin use in Type 2 Diabetes Dr Rick Cutfield Why? When? How? 1 Conflict of Interest I have been on advisory boards or had speaker fees from the following pharmaceutical companies: - Eli Lilly - Novo
More informationDiabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
More informationTrends in Prescribing of Drugs for Type 2 Diabetes in General Practice in England (Chart 1) Other intermediate and long-acting insulins
Type 2 Diabetes Type 2 diabetes is the most common form of diabetes, accounting for 90 95% of cases. 1 Charts 1 and 2 reflect the effect of increasing prevalence on prescribing and costs of products used
More informationUser guide Basal-bolus Insulin Dosing Chart: Adult
Contacts and further information Local contact Clinical pharmacy or visiting pharmacy Diabetes education service Director of Medical Services Visiting or local endocrinologist or diabetes physician For
More informationInitiate Atorvastatin 20mg daily
Type 2 Diabetes Patient Objectives Stopping Smoking BMI > 25 kg m² Control BP to
More informationUnderstanding Your Diabetes HELPLINE: 01604 622837 www.iddtinternational.org
I ndepend ent DI abetes t rust Understanding Your Diabetes HELPLINE: 01604 622837 www.iddtinternational.org INDEPENDENT DIABETES TRUST The Trust offers support, understanding and information to people
More informationPharmacological Glycaemic Control in Type 2 Diabetes
Pharmacological Glycaemic Control in Type 2 Diabetes Aim(s) and Objective(s) This guideline aims to offer advice on the pharmacological management for those who require measures beyond diet and exercise
More informationNewcastle Mitochondrial Disease Guidelines
Newcastle Mitochondrial Disease Guidelines Diabetes Mellitus in Adult Mitochondrial Disease: Screening and Initial Management First published March 2013 Updated December 2013 1 Contents Introduction 4
More informationInitiating & titrating insulin & switching in General Practice Workshop 1
Initiating & titrating insulin & switching in General Practice Workshop 1 Workshop goal To make participants comfortable in the timely initiation and titration of insulin Progression of Type 2 Diabetes
More informationGuideline for Insulin Therapeutic Review in patients with Type 2 Diabetes
Diabetes Sans Frontières Guideline for Insulin Therapeutic Review in patients with Type 2 Diabetes 1. Introduction This guideline has been developed in order to support practices to undertake insulin therapeutic
More informationGlycaemic Control in Adults with Type 1 Diabetes
Glycaemic Control in Adults with Type 1 Diabetes Aim(s) and objective(s) This document aims to provide guidance on good clinical practice in managing glycaemic control in adult patients with Type 1 Diabetes
More informationLeicestershire Diabetes Guidelines: Insulin Therapy
Endorsed by Leicestershire Medicines Strategy Group Leicestershire Diabetes Guidelines: Insulin Therapy These guidelines are designed for use by those trained and competent in insulin initiation and management
More informationInformation for Patients
Information for Patients Guidance for Diabetic Persons having bowel preparation for a flexible sigmoidoscopy or a colonoscopy or a combined gastroscopy and colonoscopy This guidance is provided to assist
More informationINSULIN INITIATION IN TYPE 2 DIABETES IN PRIMARY CARE
INSULIN INITIATION IN TYPE 2 DIABETES IN PRIMARY CARE We welcome feedback on this policy and the way it operates. We are interested to know of any possible or actual adverse impact that this policy/procedure
More informationThe GP Update Handbook Spring 2013
The GP Update Handbook Spring 2013 www.gp-update.co.uk GP Update Limited Type 2 Diabetes NICE and SIGN guidelines for type 2 diabetes...58 Diagnostic criteria for type 2 diabetes and pre-diabetes...58
More informationRenal Disease in Type 2 Diabetes Mellitus
Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman
More informationType 2 Diabetes. Aims and Objectives. What did you consider? Case Study One: Miss S. Which to choose?!?! Modes of Action
Aims and Objectives This session will outline the increasing complexities of diabetes care, and the factors that differentiate the combinations of therapy, allowing individualisation of diabetes treatment.
More informationLead Clinician(S) (DATE) Approved by Diabetes Directorate on: Approved by Medicines Safety Group on: This guideline should not be used after end of:
Guideline for members of the diabetes team and dietetic department for advising on insulin dose adjustment and teaching the skills of insulin dose adjustment to adults with type 1 or type 2 diabetes mellitus
More informationType 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment. Bruce Latham, M.D. Endocrine Specialists Greenville Health System
Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment Bruce Latham, M.D. Endocrine Specialists Greenville Health System Objectives for this presentation - Understand the thrifty genotype
More informationManaging diabetes in the post-guideline world. Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ)
Managing diabetes in the post-guideline world Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ) Overview Pathogenesis of T2DM Aims of treatment The place of glycaemic control Strategies to improve glycaemic
More informationMary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes
Mary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes Objectives Pathophysiology of Diabetes Acute & Chronic Complications Managing acute emergencies Case examples 11/24/2014 UWHealth
More informationEnd of Life Diabetes Care
End of Life Diabetes Care Commissioned by Diabetes UK Supplementary Documents and Flowcharts Endorsed By: Diabetes Phases of End of Life and Medications A - Blue: All From Diagnosis Stable With Year Plus
More informationType 2 Diabetes: When to Initiate And Intensify Insulin Therapy. Julie Bate on behalf of: Dr John Wilson Endocrinologist Capital and Coast DHB
Type 2 Diabetes: When to Initiate And Intensify Insulin Therapy Julie Bate on behalf of: Dr John Wilson Endocrinologist Capital and Coast DHB Declarations I have received travel funding and speaker fees
More informationType 2 Diabetes. Tabinda Dugal GP Day 4/05/16
Type 2 Diabetes Tabinda Dugal GP Day 4/05/16 Diabetes Diabetes.a growing health crisis in Britain 869m per year 10% of NHS budget Projections.. 5 million by 2025 Youngest patient? T2DM Type 2 diabetes
More informationCara Liday, PharmD, CDE Associate Professor, Idaho State University Clinical Pharmacist and CDE, InterMountain Medical Center Pocatello, ID The planners and presenter have disclosed no conflict of interest,
More informationPrescribing for Diabetes. England 2005-06 to 2013-14
Prescribing for Diabetes England 2005-06 to 2013-14 Published 12 August 2014 We are the trusted national provider of high-quality information, data and IT systems for health and social care. www.hscic.gov.uk
More informationTYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU
TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU Objectives: 1. To discuss epidemiology and presentation
More informationThe Early Use of Insulin and Oral Anti diabetic Drugs
The Early Use of Insulin and Oral Anti diabetic Drugs NPS Outreach Pharmacists for Remote Aboriginal Health Services Strategy A remote perspective Dr Hugh Heggie National Medicine Policy To provide timely
More informationManaging the risks of commencing insulin therapy for patients with type 2 diabetes
Managing the risks of commencing insulin therapy for patients with type 2 diabetes Laila King June 213 213 The Health Foundation Insulin is a remedy primarily for the wise, and not for the foolish, whether
More informationDiabetes Fundamentals
Diabetes Fundamentals Prevalence of Diabetes in the U.S. Undiagnosed 10.7% of all people 20+ 23.1% of all people 60+ (12.2 million) Slide provided by Roche Diagnostics Sources: ADA, WHO statistics Prevalence
More informationINSULIN INTENSIFICATION: Taking Care to the Next Level
INSULIN INTENSIFICATION: Taking Care to the Next Level By J. Robin Conway M.D., Diabetes Clinic, Smiths Falls, ON www.diabetesclinic.ca Type 2 Diabetes is an increasing problem in our society, due largely
More informationINSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT?
INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT? MARTHA M. BRINSKO, MSN, ANP-BC CHARLOTTE COMMUNITY HEALTH CLINIC CHARLOTTE, NC Diagnosed and undiagnosed diabetes in the United
More informationUnderstanding diabetes Do the recent trials help?
Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.
More informationWhen and how to start insulin: strategies for success in type 2 diabetes
1 When and how to start insulin: strategies for success in type diabetes Treatment of type diabetes in 199: with each step treatment gets more complex Bruce H.R. Wolffenbuttel, MD PhD Professor of Endocrinology
More informationInsulin myths and facts
london medicines evaluation network Insulin myths and facts Statement 1 Insulin is the last resort for patients with Type 2 diabetes After initial metformin and sulfonylurea therapy, NICE and SIGN suggest
More informationInsulin switch & Algorithms Rotorua GP CME June 2011. Kingsley Nirmalaraj FRACP Endocrinologist BOPDHB
Insulin switch & Algorithms Rotorua GP CME June 2011 Kingsley Nirmalaraj FRACP Endocrinologist BOPDHB Goal of workshop Insulin switching make the necessary move Ensure participants are confident with Recognising
More informationOverview and update of modern type 2 Diabetes philosophy and management. Dr Steve Stanaway Consultant Endocrinologist BCU
Overview and update of modern type 2 Diabetes philosophy and management Dr Steve Stanaway Consultant Endocrinologist BCU Diabetes economics 2009: 2.6M adults with DM in UK (90% type 2) 2025: est. > 4M
More informationHarmony Clinical Trial Medical Media Factsheet
Overview Harmony is the global Phase III clinical trial program for Tanzeum (albiglutide), a product developed by GSK for the treatment of type 2 diabetes. The comprehensive program comprised eight individual
More informationDouble Diabetes: Definition, Diagnosis, Treatment, Prediction and Prevention.
Double Diabetes: Definition, Diagnosis, Treatment, Prediction and Prevention. Professor Paolo Pozzilli University Campus Bio-Medico, Rome Institute of Cell & Molecular Science, Queen Mary, University of
More informationPrescribing for Diabetes, England 2005-06 to 2012-13
Prescribing for Diabetes, England 2005-06 to 2012-13 Published 13 August 2013 This product is relevant to members of the public and other stakeholders to support the understanding of primary care prescribing
More informationNutrition Therapy in Diabetes Mellitus. Dorothy Debrah Diabetes Specialist Dietitian University Hospital, Llandough. Wales, UK February 2012
Nutrition Therapy in Diabetes Mellitus. Dorothy Debrah Diabetes Specialist Dietitian University Hospital, Llandough. Wales, UK February 2012 University Hospital Llandough DIABETES MELLITUS. Definition:
More informationA Guide to Monitoring Blood Glucose for Patients with diabetes in Care Homes
A Guide to Monitoring Blood Glucose for Patients with diabetes in Care Homes 1. Summary... 1 2. Background... 2 3. Purpose 2 4. Responsibilities. 2 5. Blood Glucose Monitoring. 2 6. Resident Groups that
More informationComparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians
Clinician Research Summary Diabetes Type 2 Diabetes Comparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians A systematic review of 166 clinical studies published between
More informationType 2 Diabetes - Referral Criteria to Specialist Services
Diabetes Pathway Contact Tel: 023 8028 6401 Fax: 023 8028 6407 Mon-Fri 9.00am-5.00pm Email: hp-tr.diabetes@nhs.net Consultants email: kate.fayers@southernhealth.nhs.uk hermione.price@southernhealth.nhs.uk
More informationAdd: 2 nd generation sulfonylurea or glinide or Add DPP-4 inhibitor Start or intensify insulin therapy if HbA1c goals not achieved with the above
Guidelines for Type Diabetes - Diagnosis Fasting Plasma Glucose (confirm results if borderline) HbAIC Normal FPG < 00 < 5.5 Impaired Fasting Glucose (IFG) 00 to < 5.7%-.5% Diabetes Mellitus (or random
More informationCancer treatment and diabetes
Cancer treatment and diabetes Dr Daniel Morganstein Consultant Endocrinologist, 1 2 Diabetes and cancer Cancer and its treatment also poses challenges to managing diabetes Surgery Altered appetite Cachexia
More informationDR. Trinh Thi Kim Hue
TYPE 2 DIABETES IN THE CHILD AND ADOLESCENT DR. Trinh Thi Kim Hue CONTENTS Definition Diagnosis Treatment Comorbidities and Complications Comorbidities and Complications Screening for T2D References DEFINITION
More informationINSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT
INSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT APIRADEE SRIWIJITKAMOL DIVISION OF ENDOCRINOLOGY AND METABOLISM DEPARTMENT OF MEDICINE FACULTY OF MEDICINE SIRIRAJ HOSPITOL QUESTION 1 1. ท านเคยเป นแพทย
More informationManagement of diabetes
SIGN Scottish Intercollegiate Guidelines Network Part of NHS Quality Improvement Scotland Help us to improve SIGN guidelines - click here to complete our survey 116 Management of diabetes A national clinical
More informationClinical Assistant Professor. Clinical Pharmacy Specialist Wesley Family Medicine Residency Program. Objectives
What s New in Diabetes Medications? Matthew Kostoff, PharmD, BCPS, BCACP Clinical Assistant Professor Clinical Pharmacy Specialist Wesley Family Medicine Residency Program Objectives Discuss new literature
More informationInsulin onset, peak and duration of action
Insulin onset, peak and duration of action Insulin was first discovered in the early 190 s. Before then, diabetes could not be treated. Insulin was then taken from cow and pig pancreases, but nearly all
More informationTYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
More informationDRUGS FOR GLUCOSE MANAGEMENT AND DIABETES
Page 1 DRUGS FOR GLUCOSE MANAGEMENT AND DIABETES Drugs to know are: Actrapid HM Humulin R, L, U Penmix SUNALI MEHTA The three principal hormones produced by the pancreas are: Insulin: nutrient metabolism:
More informationSummary of the risk management plan (RMP) for Xultophy (insulin degludec / liraglutide)
EMA/467911/2014 Summary of the risk management plan (RMP) for Xultophy (insulin degludec / liraglutide) This is a summary of the risk management plan (RMP) for Xultophy, which details the measures to be
More informationUpdate on the management of Type 2 Diabetes
Update on the management of Type 2 Diabetes Mona Nasrallah M.D Assistant Professor, Endocrinology American University of Beirut 10 th Annual Family Medicine Conference October 14,2011 Global Prevalence
More informationTreatment of patients with type 2 diabetes: from text book therapy to personalized medicine
1 Treatment of patients with type 2 diabetes: from text book therapy to personalized medicine BruceH H.R. Wolffenbuttel, MDPhD Professor of Endocrinology & Metabolism University Medical Center Groningen
More informationA patient s guide to the. management of diabetes at the time of surgery
A patient s guide to the management of diabetes at the time of surgery Diabetes is a common condition, affecting at least 4 to 5% of people in the UK. At least 10% of patients undergoing surgery have diabetes.
More informationType 2 Diabetes. Management and Medication. HELPLINE: 01604 622837 www.iddtinternational.org
I N D E P E N D E N T D I A B E T E S T R U S T Type 2 Diabetes Management and Medication A charity supporting and listening to people who live with diabetes HELPLINE: 01604 622837 www.iddtinternational.org
More informationCASE B1. Newly Diagnosed T2DM in Patient with Prior MI
Newly Diagnosed T2DM in Patient with Prior MI 1 Our case involves a gentleman with acute myocardial infarction who is newly discovered to have type 2 diabetes. 2 One question is whether anti-hyperglycemic
More informationThis guideline is the NICE Diabetes in Pregnancy guideline with additions where appropriate to explain implementation within UHL.
Diabetes in pregnancy. Scope: This guideline applies to the management of diabetes and its complications from preconception to the postnatal period. This applies to obstetric, midwifery, neonatology and
More informationDudley Diabetes Management Guidelines for Adults with Type 2 Diabetes
Dudley Diabetes Management Guidelines for Adults with Type 2 Diabetes June 2016 Review date: June 2017 enable clinicians who are using them to update the information that has been provided 1 The Dudley
More informationSpecialist Clinics Day Regularity Site Contact
Type 2 Diabetes - Diagnosis Referral Criteria and Screening to Specialist Services National Service Framework Standard 2 Same Day Referral Newly diagnosed Children with Diabetes - refer to Paediatric Service
More informationPeri-Operative Guidelines for Management of Diabetes Patients
Peri-Operative Guidelines for Management of Diabetes Patients Target blood glucose 6-10 mmol/l for all patients Acceptable blood glucose 4-11 mmol/l for all patients Definitions Non-Insulin Glucose Lowering
More informationInsulin Pump Therapy
CHILDREN S SERVICES Insulin Pump Therapy These guidelines are not intended for starting a patient on an insulin pump. They are intended to give staff not part of the diabetic team information regarding
More informationCochrane Quality and Productivity topics
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus NICE has developed the Cochrane Quality and Productivity (QP) topics to help the NHS identify practices
More informationof Treatment Options for Type 2 Diabetes Patients
Guidance Pack East Surrey CCG Guildford & Waverley CCG North West Surrey CCG Surrey Downs CCG Surrey Heath CCG North East Hampshire & Farnham CCG Crawley CCG Horsham & Mid-Sussex CCG of Treatment Options
More informationDOCUMENT CONTROL PAGE
DOCUMENT CONTROL PAGE Document Number: GUI/CL/WCN/666 Version Number: Version 2 Title: Guidelines for the management of inpatient diabetes, including the management of diabetic emergencies and the management
More informationInsulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.
Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused
More information4. Does your PCT provide structured education programmes for people with type 2 diabetes?
PCT Prescribing Report Drugs used in Type 2 Diabetes Discussion Points 1. Does your PCT have a strategy for prevention of type 2 diabetes? Does your PCT provide the sort of intensive multifactorial lifestyle
More informationApproximate Cost Reference List i for Antihyperglycemic Agents
Alpha Glucosidase Inhibitor Acarbose (Glucobay ) Biguanides Metformin (Glucophage, generic) Metformin ER (Glumetza ) Approximate Cost Reference List i for Antihyperglycemic Agents Incretin Agents - DPP-4
More informationDIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria
DIABETES MELLITUS By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria What is Diabetes Diabetes Mellitus (commonly referred to as diabetes ) is a chronic medical
More informationChapter 4 Type 2 Diabetes
Chapter 4 Type 2 Diabetes (previously referred to as adult onset diabetes or non-insulin dependent diabetes) H. Peter Chase, MD Cindy Cain, RN, CDE Philip Zeitler, MD This is the most common type of diabetes
More informationTreating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference
Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group Learning Objectives To accurately make the diagnosis of pre-diabetes/metabolic syndrome To understand the prevalence
More informationNICE guideline Published: 26 August 2015 nice.org.uk/guidance/ng17
Type 1 diabetes in adults: diagnosis and management NICE guideline Published: 26 August 2015 nice.org.uk/guidance/ng17 NICE 2015. All rights reserved. Last modified November 2015 Contents Introduction...
More informationAbdulaziz Al-Subaie. Anfal Al-Shalwi
Abdulaziz Al-Subaie Anfal Al-Shalwi Introduction what is diabetes mellitus? A chronic metabolic disorder characterized by high blood glucose level caused by insulin deficiency and sometimes accompanied
More informationManagement of Children with newly diagnosed type 1 diabetes (up until their 18th Birthday)
Title: Author: Speciality / Division: Directorate: CLINICAL GUIDELINES ID TAG Management of Children with newly diagnosed type 1 diabetes (up until their 18th Birthday) Dr Teresa Mulroe and Dr Sarinda
More informationThis information explains the advice about type 2 diabetes in adults that is set out in NICE guideline NG28.
Information for the public Published: 2 December 2015 nice.org.uk About this information NICE guidelines provide advice on the care and support that should be offered to people who use health and care
More informationTreatment of Type 2 Diabetes
Improving Patient Care through Evidence Treatment of Type 2 Diabetes This information is based on a comprehensive review of the evidence for best practices in the treatment of type 2 diabetes and is sponsored
More informationtrends in the treatment of Diabetes type 2 - New classes of antidiabetic drugs. IAIM, 2015; 2(4): 223-
Review Article Pharmacological trends in the treatment of Diabetes type 2 - New classes of antidiabetic Silvia Mihailova 1*, Antoaneta Tsvetkova 1, Anna Todorova 2 1 Assistant Pharmacist, Education and
More informationManagement of Diabetes: A Primary Care Perspective. Presentation Outline
Management of Diabetes: A Primary Care Perspective Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest Presentation Outline
More informationG:\ CDM\BHCIG Diabetes Pathway FINAL September 05.doc 1
G:\ CDM\BHCIG Diabetes Pathway FINAL September 05.doc 1 BHCiG: TYPE 2 DIABETES MANAGEMENT PATHWAY MODEL INTRODUCTION What is the aim of the model? To improve the capacity of primary care health practitioners
More informationJill Malcolm, Karen Moir
Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are
More informationInsulin therapy in type 2 diabetes When and how? Disclosures. Learning Objectives. None relevant to today s talk
Insulin therapy in type 2 diabetes When and how? Cecilia C Low Wang, MD Univ Colorado AMC SOM Department of Medicine Division of Endocrinology, Metabolism, and Diabetes Disclosures None relevant to today
More informationDiabetes: When To Treat With Insulin and Treatment Goals
Diabetes: When To Treat With Insulin and Treatment Goals Lanita. S. White, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor of Pharmacy Practice, UAMS College of Pharmacy
More informationNutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT
1 Nutrition Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT 2 Type 2 Diabetes: A Growing Challenge in the Healthcare Setting Introduction and background of type 2 diabetes:
More informationInstitute of Applied Health Sciences. University of Aberdeen DATABASE REVIEW. Grampian University. Hospitals NHS Trust GRAMPIAN DIABETES
DATABASE REVIEW Grampian University Hospitals NHS Trust GRAMPIAN DIABETES SERVICES DATABASE Page 1 Contents Contents 2 Introduction 3 History 3 Overview of Database 3 Database Structure 4 Main Table Summary
More informationNICE guideline Published: 26 August 2015 nice.org.uk/guidance/ng18
Diabetes (type 1 and type 2) in children and young people: diagnosis and management NICE guideline Published: 26 August 2015 nice.org.uk/guidance/ng18 NICE 2015. All rights reserved. Contents Introduction...
More informationDiabetes mellitus. Lecture Outline
Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized
More informationHyperosmolar Non-Ketotic Diabetic State (HONK)
Hyperosmolar Non-Ketotic Diabetic State (HONK) University Hospitals of Leicester NHS Trust Guidelines for Management of Acute Medical Emergencies Management is largely the same as for diabetic ketoacidosis
More informationUpdates for your practice March, 2013. Vol 2, Issue 14 TLALELETSO. Managing Complicated Diabetes
dates for your practice March, 2013. Vol 2, Issue 14 TLALELETSO Managing Complicated Diabetes Diabetes is increasingly common Managing diabetes and working as part of a multidisciplinary team is essential
More informationMetabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
More informationTreating Type 2 Diabetes Mellitus: a New York State Medicaid Clinical Guidance Document
Treating Type 2 Diabetes Mellitus: a New York State Medicaid Clinical Guidance Document Disclaimer: This document is offered as a service to New York State Prescribers to inform about the most current
More informationType 2 Diabetes in Children
Type 2 Diabetes in Children February 19, 2005 Brandon Nathan, MD Endocrinology Department of Pediatrics University of Minnesota Medical School University of Minnesota Masonic Children s Hospital Agenda
More information